Genoscience Pharma Is Innovating to Change the Cancer Landscape

To design, develop and commercialize novel therapies intended to improve patients' quality of life and resolve serious unmet medical healthcare needs

Genoscience Approach

One of the fundamental challenges in cancer treatment is cancer resistance and relapse. A reason for this acquired resistance may be the presence of small minority of cells in the tumor called cancer stem cells (CSC). Most current anti-cancer chemotherapeutics primarily target either differentiated or proliferating cancer cells, and concretively, will not be effective against CSCs.

Discover

Pipeline

With more than 780,000 new cases diagnosed every year, liver cancer is the fifth most common cancer worldwide. Almost 400,000 new cases are diagnosed annually in China, Japan and South Korea, 52,000 in the EU and about 30,000 in the United States. Men are significantly more affected overall than women.
Liver cancer causes death more often than many other tumors, and patients are usually diagnosed with late-stage disease.

Discover

News

News
10 December 2018

Most Innovative European Biotech SME for 2018

Company receives award in healthcare category for cancer therapy in clinical development with an action…
Read More
News
9 November 2018

Raphaël Rodriguez: Winner 2019 Tetrahydron Young Investigator Award

Genoscience Pharma is proud to announce that one of the members of its Scientific Advisory…
Read More
News
October 5, 2018

Extension to US of GNS561 Clinical Trial

Genoscience Pharma Extends to US its Clinical Trial in Patients with Advanced Liver Cancers  …
Read More

Events

Events
October 3-6, 2018

83èmes Journées Scientifiques de l’AFEF 2018

83èmes Journées Scientifiques de l'AFEF 2018 - Lyon , France     During an amazing…
Read More
Events
April 11-15, 2018

The EASL-International Liver Congress Meeting 2018

The EASL-International Liver Congress Meeting 2018 - Paris, France     Genoscience Pharma was present…
Read More
Events
October 20-24, 2017

The AASLD-Liver Meeting 2017

The AASLD - Liver Meeting 2017- Washigton, D.C., USA     The American Association for…
Read More

Bringing a new hope to cancer patients by providing innovative approaches for a better care

Philippe Halfon, CEO of Genoscience Pharma